BTIG Research Initiates Coverage On Pacira BioSciences with Buy Rating, Announces $56 Price Target

BTIG Research initiates coverage on Pacira BioSciences (NASDAQ:PCRX) with a Buy rating and a $56 price target.

Benzinga · 11/06/2019 11:39

BTIG Research initiates coverage on Pacira BioSciences (NASDAQ:PCRX) with a Buy rating and a $56 price target.